Judge Reduces Johnson & Johnson Opioid Verdict by More Than $100 Million
A judge in Oklahoma has reduced a verdict against opioid maker Johnson & Johnson by more than $100 million, NPR reports.
Addiction doctors say insurance barriers to opioid addiction treatment are putting people’s lives at risk, USA Today reports.
“The fact that you have to fight with these insurance companies and jump through a thousand different hoops – it can be a matter of life and death,” said Kaitlyn Mishlen, research clinician at Columbia University Department of Psychiatry.
A new study by the IMS Institute for Healthcare Informatics and the Advocates for Opioid Recovery found that of the 10 states with the highest prescription opioid use relative to their population, eight states have a lower than national average level of Medicaid funding for buprenorphine use.
The study found patient access to – and reimbursement for – buprenorphine medications used in addiction recovery programs varies widely across states and “suggests inconsistent and suboptimal approaches in many parts of the country.”
Want to learn more about medication-assisted treatment? Read the Partnership’s Medication-Assisted Treatment eBook.